Searchable abstracts of presentations at key conferences in endocrinology

ea0063p286 | Pituitary and Neuroendocrinology 1 | ECE2019

Spinal Epidural Lipomatosis: A rare complication of Cushing’s disease

Scholz AFM , Min T , Smeeton F , Davies JS , Hayhurst C , Rees A , Lansdown A

Background: Spinal Epidural Lipomatosis (SEL) is an excessive fat deposition in the spinal canal which can lead to compression of nervous structures. SEL is a rare but recognised side effect of exogenous steroid excess. There are only six previously reported cases of SEL associated with endogenous steroid excess in the available literature. We present a case of SEL, caused by Cushing’s disease, that presented in the immediate post-operative period.C...

ea0044p28 | Adrenal and Steroids | SFEBES2016

Incidence and outcomes of hormone-secreting adrenal tumours in pregnancy: a UK 4 year prospective cohort study

Quartermaine Georgia , Lambert Kimberley , Rees Kate , Seed Paul , Dhanjal Mandish , Knight Marian , McCance DR , Williamson Catherine

Objective: To examine the monitoring, management and outcomes of adrenal tumours in pregnancy.Design: A national, prospective observational, cohort study over 4 years using the UK Obstetric Surveillance System (UKOSS).Setting: Consultant led obstetric units.Patients: Women with hormone-secreting adrenal tumours (pheochromocytoma, primary aldosteronism or Cushing’s syndrome) diagnosed before or during pre...

ea0059p216 | Thyroid | SFEBES2018

Management of ‘Anomalous’ thyroid results

Souza Lezia D , Evans Carol , Lansdown Andrew , Rees D Aled , Premawardhana Lakdasa

Background/objectives: While patients are commonly referred to endocrinology with a low FT4 and normal TSH, there is no consistency in the management of these patients. The aim of this audit was to assess management of these patients including investigation, diagnosis and pharmacological intervention and compare to the current Association for Clinical Biochemistry guidelines.Methods: This was a retrospective audit studying 41 endocrine outpatients at Uni...

ea0034p355 | Steroids | SFEBES2014

Patient education and steroid replacement regimens in adrenal insufficiency

Ameen Zana , Ulnasah Sadaf , Rees Jo , Shepherd Lisa , Bates Andrew , Rahim Asad

Introduction: Adrenal insufficiency (primary/secondary) is a rare and potentially life-threatening condition which can be easily overlooked. Patient awareness and management of problems is critical and central to effective treatment. The NICE Clinical Knowledge Summaries for patients identifies and recommends critical areas that require attention in adrenal insufficiency. In particular, patients should:i) Realize the need for lifelong glucocorticoid repl...

ea0070aep505 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Challenging hypoglycaemia management in a patient with metastatic insulinoma

Giannopoulou Angeliki , Surya Ashutosh , Nidumolu Ravi , Witczak Justyna , Kumar Nagappan , Rees Aled

Background: Metastatic insulinomas are very rare (fewer than 1:100000) and therefore may pose a therapeutic challenge as there are no case controlled studies comparing the efficacy of various therapeutic approaches avialable. The Ki 67 index from the histology of the primary tumour is an established prognostic marker for metastatic disease with tumours showing low Ki 67(<3%) being defined as low risk of early recurrence.Case Presentation: A 60 year o...

ea0031oc4.6 | Obesity, metabolism and bone | SFEBES2013

Transgenic disruption of 5α-reductase 1 increases susceptibility to liver fibrosis

Livingstone Dawn , Rees Georgina , Weldin Benjamin , MacFarlane David , Walker Brian , Andrew Ruth

5α-Reductase 1 (5aR1) catalyses A-ring reduction of glucocorticoids and androgens, predominantly in liver and modulates steroid hormone action. We previously demonstrated transgenic disruption of 5aR1 predisposes mice to developing fatty liver. Here we tested whether 5aR1 disruption increases susceptibility to the development of liver injury, using the carbon tetrachloride induced liver fibrosis model.Male 5aR1−/− (KO) mice and wild-type...

ea0031p38 | Clinical biochemistry | SFEBES2013

Development of an inductively coupled plasma-mass spectrometry method for measurement of urine iodine and assessment of iodine status in subclinical hypothyroidism

Jones Katie , Rogers Joanne , De Lloyd Anna , Rees Aled , Ludgate Marian , Evans Carol

Iodine deficiency may lead to reduced thyroid hormone production and ultimately hypothyroidism. The UK has previously been considered to be iodine sufficient, however recent evidence suggests the UK may be iodine deficient. Iodine status can be assessed in several ways, including measurement of urinary iodine excretion, for which inductively coupled plasma-mass spectrometry (ICP-MS) is considered the gold standard method.An ICP-MS method for determinatio...

ea0025p58 | Clinical biochemistry | SFEBES2011

Long-term single centre outcome of phaeochromocytoma/paraganglioma

Al-Kutubi Huda , Greenwood Joanne , Udiawar Maneesh , Kalhan Atul , Scott-Coombes David , Rees Aled

Background: Phaeochromocytomas (PHAEOs) and paragangliomas (PGLs) are rare catecholamine producing tumours which are potentially lethal if left untreated and may be associated with a wide variety of complications. Optimum management demands multidisciplinary input from endocrinologists, biochemists, geneticists and endocrine surgeons.Objective: A retrospective audit into the management of PHAEOs/PGLs at our institution against the 2005 recommendations ma...

ea0025p59 | Clinical biochemistry | SFEBES2011

An analysis of false positive urinary catecholamine and metabolite results in a tertiary endocrine centre

Al-Kutubi Huda , Greenwood Joanne , Kalhan Atul , Udiawar Maneesh , Rees Aled

Background: The screening investigation of choice for phaeochromocytomas (PHAEO) and paragangliomas (PGL) in the UK is usually a 24 h urine collection for fractionated metadrenalines +/− free catecholamines. These assays have high diagnostic sensitivity (approaching 98%) but lower specificity.Aim: To review causes of false positive (FP) catecholamine and metabolite results in our centre over a 12-year period.Methods: Data wer...

ea0025p173 | Endocrine tumours and neoplasia | SFEBES2011

Adenosine receptors modulate chromogranin A secretion and growth of neuroendocrine tumours: potential targets for therapy

Kalhan Atul , Garibi Borzo , Jasani Bharat , Kidd Mark , Modlin Irvin , Pfragner Roswitha , Rees Aled , Ham Jack

Introduction: Neuroendocrine tumors of GI tract are a heterogeneous group of rare neoplasms that secrete peptides and amines. These tumors are highly vascular and their vascularity reflects increased tumour related angiogenesis. Adenosine, a major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.Material and methods: The expression of adenosine receptors (AR) was investigated in two human n...